Ventyx Financial Statements From 2010 to 2024

Stocks . USA . 
Stock . Ventyx Biosciences
VTYX Stock  USD 2.65  0.11  4.33%   
Ventyx Biosciences financial statements provide useful quarterly and yearly information to potential Ventyx Biosciences investors about the company's current and past financial position, as well as its overall management performance and changes in financial position over time. Historical trend examination of various income statement and balance sheet accounts found on Ventyx Biosciences financial statements helps investors assess Ventyx Biosciences' valuation, profitability, and current liquidity needs. Key fundamental drivers impacting Ventyx Biosciences' valuation are summarized below:
Market Capitalization
187.4 M
Earnings Share
(2.35)
We have found one hundred ten available fundamental trend indicators for Ventyx Biosciences, which can be analyzed and compared to other ratios and to its competition. All investors should make sure to double-check all of Ventyx Biosciences current market performance against the performance between 2010 and 2024 to make sure the company can sustain itself down the road. Market Cap is likely to drop to about 967.2 M in 2024. Enterprise Value is likely to drop to about 943.6 M in 2024
Check Ventyx Biosciences financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Ventyx Biosciences' main balance sheet or income statement drivers, such as Net Interest Income of 15.4 M, Depreciation And Amortization of 150.1 K or Interest Expense of 5.7 M, as well as many indicators such as Price To Sales Ratio of 0.0, Dividend Yield of 0.0 or PTB Ratio of 0.62. Ventyx financial statements analysis is a perfect complement when working with Ventyx Biosciences Valuation or Volatility modules.
  
Check out the analysis of Ventyx Biosciences Correlation against competitors.
For more information on how to buy Ventyx Stock please use our How to Invest in Ventyx Biosciences guide.

Ventyx Biosciences Balance Sheet

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Total Assets207.1 M277.7 M76.8 M
Slightly volatile
Short and Long Term Debt Total8.4 M12.5 M5 M
Slightly volatile
Other Current Liabilities16.3 M15.5 M3.4 M
Slightly volatile
Total Current Liabilities11.6 M22.3 M4.7 M
Slightly volatile
Accounts Payable4 M5.8 M1.7 M
Slightly volatile
Cash41.3 M51.6 M15.5 M
Slightly volatile
Long Term Debt9.1 M14.5 M6.7 M
Slightly volatile
Cash And Short Term Investments197.1 M252.2 M73.1 M
Slightly volatile
Common Stock Shares Outstanding57.6 M58.5 M51.5 M
Slightly volatile
Non Current Liabilities Total8.1 M11.5 M6.2 M
Slightly volatile
Other Current Assets6.5 M12.1 M2.4 M
Slightly volatile
Other Stockholder Equity361.6 M663.2 M133.8 M
Slightly volatile
Total Liabilities21.8 M33.8 M10.7 M
Slightly volatile
Total Current Assets188.9 M264.3 M70 M
Slightly volatile
Other Liabilities13.5 M15.2 M16.5 M
Slightly volatile
Non Currrent Assets Other1.1 M1.1 M201.6 K
Slightly volatile
Net Receivables840 K800 K163.7 K
Slightly volatile
Common Stock Total Equity6 K6.9 K5.3 K
Slightly volatile
Capital Surpluse538.1 M668.4 M436.8 M
Slightly volatile
Common Stock6.2 K6.9 K5.3 K
Slightly volatile
Property Plant Equipment363.6 K468.1 K285.8 K
Slightly volatile
Short Term Debt1 M1 M847.8 K
Slightly volatile

Ventyx Biosciences Income Statement

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Interest Expense5.7 M5.4 M1.2 M
Slightly volatile
Selling General Administrative33.8 M32.2 M7.1 M
Slightly volatile
Other Operating Expenses218.4 M208 M43.7 M
Slightly volatile
Research Development184.6 M175.8 M36.6 M
Slightly volatile
Total Operating Expenses218.4 M208 M43.7 M
Slightly volatile
Interest Income15.4 M14.6 M2.4 M
Slightly volatile
Preferred Stock And Other Adjustments1.2 M1.4 M1.5 M
Slightly volatile
Cost Of Revenue528.4 K941 K153.3 K
Slightly volatile
Selling And Marketing Expenses0.80.90.98
Slightly volatile

Ventyx Biosciences Cash Flow Statement

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Net Borrowings384.8 K405 K2.5 M
Slightly volatile
Stock Based Compensation30 M28.6 M5.3 M
Slightly volatile
Other Cashflows From Financing Activities4.7 M4.9 M15.7 M
Pretty Stable
Depreciation988 K941 K183.9 K
Slightly volatile
Capital Expenditures346.5 K514 K285.3 K
Slightly volatile
Total Cash From Financing Activities50.7 M53.3 M42.1 M
Slightly volatile
End Period Cash Flow41.5 M52.6 M15.5 M
Slightly volatile
Change To Netincome22 M19.1 M8.7 M
Slightly volatile
Change To Liabilities4.2 M4 M1.2 M
Slightly volatile
Sale Purchase Of Stock237.5 K250 K258.5 M
Slightly volatile
Exchange Rate Changes8.8 K9.9 K10.8 K
Slightly volatile
Other Cashflows From Investing Activities1.5 M1.7 M1.9 M
Slightly volatile

Financial Ratios

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Capex To Depreciation0.520.54627.0968
Slightly volatile
Payables Turnover0.170.16350.0323
Slightly volatile
Cash Per Share2.484.30841.2029
Slightly volatile
Days Payables Outstanding2.1 K2.2 K46 K
Slightly volatile
Income Quality0.490.8630.6034
Very volatile
Net Debt To EBITDA0.180.18790.9074
Slightly volatile
Current Ratio8.6811.87274.5257
Slightly volatile
Graham Number18.4617.57874.4033
Slightly volatile
Capex Per Share0.00510.00880.0054
Slightly volatile
Interest Debt Per Share0.00860.0090.072
Pretty Stable
Debt To Assets0.00120.001310.7884
Pretty Stable
Days Of Payables Outstanding2.1 K2.2 K46 K
Slightly volatile
Ebt Per Ebit1.790.92771.2848
Slightly volatile
Quick Ratio8.6811.87274.5257
Slightly volatile
Net Income Per E B T1.091.151.0348
Pretty Stable
Cash Ratio2.032.31661.2762
Slightly volatile
Free Cash Flow Operating Cash Flow Ratio1.11.00311.0125
Slightly volatile
Debt Ratio0.00120.001310.7884
Pretty Stable

Ventyx Biosciences Valuation Data

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Market Cap967.2 M1.5 B1.1 B
Slightly volatile
Enterprise Value943.6 M1.5 B1.1 B
Slightly volatile

Ventyx Fundamental Market Drivers

Cash And Short Term Investments252.2 M

Ventyx Upcoming Events

28th of March 2024
Upcoming Quarterly Report
View
9th of May 2024
Next Financial Report
View
31st of December 2023
Next Fiscal Quarter End
View
28th of March 2024
Next Fiscal Year End
View
30th of September 2023
Last Quarter Report
View
31st of December 2022
Last Financial Announcement
View

About Ventyx Biosciences Financial Statements

Ventyx Biosciences investors use historical fundamental indicators, such as Ventyx Biosciences' revenue or net income, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Ventyx Biosciences. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Cost Of Revenue941 K528.4 K

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
ESRTEmpire State Realty
CCitigroup
CCitigroup

Additional Tools for Ventyx Stock Analysis

When running Ventyx Biosciences' price analysis, check to measure Ventyx Biosciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Ventyx Biosciences is operating at the current time. Most of Ventyx Biosciences' value examination focuses on studying past and present price action to predict the probability of Ventyx Biosciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Ventyx Biosciences' price. Additionally, you may evaluate how the addition of Ventyx Biosciences to your portfolios can decrease your overall portfolio volatility.
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2024 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY